Discovery of a Potent Small-Molecule Antagonist of Inhibitor of Apoptosis (IAP) Proteins and Clinical Candidate for the Treatment of Cancer (GDC-0152)

被引:195
作者
Flygare, John A. [1 ]
Beresini, Maureen [2 ]
Budha, Nageshwar [3 ]
Chan, Helen [4 ]
Chan, Iris T. [5 ]
Cheeti, Sravanthi [3 ]
Cohen, Frederick [1 ]
Deshayes, Kurt [6 ]
Doerner, Karl [7 ]
Eckhardt, S. Gail [10 ]
Elliott, Linda O. [2 ]
Feng, Bainian [1 ]
Franklin, Matthew C. [6 ]
Reisner, Stacy Frankovitz [2 ]
Gazzard, Lewis [1 ]
Halladay, Jason [4 ]
Hymowitz, Sarah G. [8 ]
La, Hank [4 ]
LoRusso, Patricia [11 ]
Maurer, Brigitte [8 ]
Murray, Lesley [7 ]
Plise, Emile [4 ]
Quan, Clifford [6 ]
Stephan, Jean-Philippe [2 ]
Young, Shin G. [4 ]
Tom, Jeffrey [6 ]
Tsui, Vickie [1 ]
Um, Joanne [1 ]
Varfolomeev, Eugene [6 ]
Vucic, Domagoj [6 ]
Wagner, Andrew J. [12 ]
Wallweber, Heidi J. A. [8 ]
Wang, Lan [1 ]
Ware, Joseph [3 ]
Wen, Zhaoyang [1 ]
Wong, Harvey [4 ]
Wong, Jonathan M. [1 ]
Wong, Melisa [1 ]
Wong, Susan [4 ]
Yu, Ron [9 ]
Zobel, Kerry [6 ]
Fairbrother, Wayne J. [6 ]
机构
[1] Genentech Inc, Dept Discovery Chem, San Francisco, CA 94080 USA
[2] Genentech Inc, Dept Biochem & Cellular Pharmacol, San Francisco, CA 94080 USA
[3] Genentech Inc, Dept Clin Pharmacol, San Francisco, CA 94080 USA
[4] Genentech Inc, Dept Drug Metab & Pharmacokinet, San Francisco, CA 94080 USA
[5] Genentech Inc, Dept Oncol Exploratory Clin Dev, San Francisco, CA 94080 USA
[6] Genentech Inc, Dept Early Discovery Biochem, San Francisco, CA 94080 USA
[7] Genentech Inc, Dept Translat Oncol, San Francisco, CA 94080 USA
[8] Genentech Inc, Dept Biol Struct, San Francisco, CA 94080 USA
[9] Genentech Inc, Dept Biostat, San Francisco, CA 94080 USA
[10] Univ Colorado Denver, Div Med Oncol, Aurora, CO 80045 USA
[11] Wayne State Univ, Dept Oncol, Barbara Ann Karmanos Canc Inst, Detroit, MI 48201 USA
[12] Dana Farber Canc Inst, Ctr Sarcoma & Bone Oncol, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
NF-KAPPA-B; STRUCTURAL BASIS; MELANOMA INHIBITOR; LINKED INHIBITOR; CELL-DEATH; BIR DOMAIN; C-IAPS; ML-IAP; XIAP; CIAP1;
D O I
10.1021/jm300060k
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of compounds were designed and synthesized as antagonists of cIAP1/2, ML-IAP, and XIAP based on the N-terminus, AVPI, of mature Smac. Compound 1 (GDC-0152) has the best profile of these compounds; it binds to the XIAP BIR3 domain, the BIR domain of ML-IAP, and the BIR3 domains of cIAP1 and cIAP2 with K-l values of 28, 14, 17, and 43 nM, respectively. These compounds promote degradation of cIAP1, induce activation of caspase-3/7, and lead to decreased viability of breast cancer cells without affecting normal mammary epithelial cells. Compound 1 inhibits tumor growth when dosed orally in the MDA-MB-231 breast cancer xenograft model. Compound 1 was advanced to human clinical trials, and it exhibited linear pharmacokinetics over the dose range (0.049 to 1.48 mg/kg) tested. Mean plasma clearance in humans was 9 +/- 3 mL/min/kg, and the volume of distribution was 0.6 +/- 0.2 L/kg.
引用
收藏
页码:4101 / 4113
页数:13
相关论文
共 63 条
[1]  
Asselin E, 2001, CANCER RES, V61, P1862
[2]   cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination [J].
Bertrand, Mathieu J. M. ;
Milutinovic, Snezana ;
Dickson, Kathleen M. ;
Ho, Wai Chi ;
Boudreault, Alain ;
Durkin, Jon ;
Gillard, John W. ;
Jaquith, James B. ;
Morris, Stephen J. ;
Barker, Philip A. .
MOLECULAR CELL, 2008, 30 (06) :689-700
[3]   A Potent and Orally Active Antagonist (SM-406/AT-406) of Multiple Inhibitor of Apoptosis Proteins (IAPs) in Clinical Development for Cancer Treatment [J].
Cai, Qian ;
Sun, Haiying ;
Peng, Yuefeng ;
Lu, Jianfeng ;
Nikolovska-Coleska, Zaneta ;
McEachern, Donna ;
Liu, Liu ;
Qiu, Su ;
Yang, Chao-Yie ;
Miller, Rebecca ;
Yi, Han ;
Zhang, Tao ;
Sun, Duxin ;
Kang, Sanmao ;
Guo, Ming ;
Leopold, Lance ;
Yang, Dajun ;
Wang, Shaomeng .
JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (08) :2714-2726
[4]   Structural and biochemical basis of apoptotic activation by Smac/DIABLO [J].
Chai, JJ ;
Du, CY ;
Wu, JW ;
Kyin, S ;
Wang, XD ;
Shi, YG .
NATURE, 2000, 406 (6798) :855-862
[5]   Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappa B control [J].
Chu, ZL ;
McKinsey, TA ;
Liu, L ;
Gentry, JJ ;
Malim, MH ;
Ballard, DW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (19) :10057-10062
[6]   Antagonists of inhibitor of apoptosis proteins based on thiazole amide isosteres [J].
Cohen, Frederick ;
Koehler, Michael F. T. ;
Bergeron, Philippe ;
Elliott, Linda O. ;
Flygare, John A. ;
Franklin, Matthew C. ;
Gazzard, Lewis ;
Keteltas, Stephen F. ;
Lau, Kevin ;
Ly, Cuong Q. ;
Tsui, Vickie ;
Fairbrother, Wayne J. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (07) :2229-2233
[7]   Orally Bioavailable Antagonists of Inhibitor of Apoptosis Proteins Based on an Azabicyclooctane Scaffold [J].
Cohen, Frederick ;
Alicke, Bruno ;
Elliott, Linda O. ;
Flygare, John A. ;
Goncharov, Tatiana ;
Keteltas, Stephen F. ;
Franklin, Matthew C. ;
Frankovitz, Stacy ;
Stephan, Jean-Philippe ;
Tsui, Vickie ;
Vucic, Domagoj ;
Wong, Harvey ;
Fairbrother, Wayne J. .
JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (06) :1723-1730
[8]   Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases [J].
Deveraux, QL ;
Leo, E ;
Stennicke, HR ;
Welsh, K ;
Salvesen, GS ;
Reed, JC .
EMBO JOURNAL, 1999, 18 (19) :5242-5251
[9]   X-linked and cellular IAPs modulate the stability of C-RAF kinase and cell motility [J].
Dogan T. ;
Harms G.S. ;
Hekman M. ;
Karreman C. ;
Oberoi T.K. ;
Alnemri E.S. ;
Rapp U.R. ;
Rajalingam K. .
Nature Cell Biology, 2008, 10 (12) :1447-1455
[10]   Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition [J].
Du, CY ;
Fang, M ;
Li, YC ;
Li, L ;
Wang, XD .
CELL, 2000, 102 (01) :33-42